Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Graha Mitra Asia Tbk. (RELF)

UBC Medical Indonesia Tbk.Trading
Graha Mitra Asia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan UBC Medical Indonesia Tbk. dan Graha Mitra Asia Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb), sedangkan Graha Mitra Asia Tbk. diperdagangkan di Rp34 (kapitalisasi pasar 200,47 M, volume 24 jam 6,25 jt). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 3,2× kapitalisasi pasar Graha Mitra Asia Tbk., dan Graha Mitra Asia Tbk. lebih aktif diperdagangkan (6,25 jt vs 843 rb). Mana yang lebih baik tergantung tujuan investasimu.

LABSRELF
Kapitalisasi Pasar
635,95 M200,47 M
Volume
843 rb6,25 jt
Lot
8,43 rb62,54 rb
Perputaran
137,6 jt209,23 jt
Harga Rata-rata
163,2233,45
Nilai Transaksi
137,6 jt209,23 jt
Harga Ekuilibrium Indikatif
16534
Volume Ekuilibrium Indikatif
2465 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS
Lihat detail
RELF
Lihat detail

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS

Tentang Graha Mitra Asia Tbk.

PT Graha Mitra Asia Tbk (hereinafter referred to as the "Company") was established based on Deed No. 15 dated 17 April 2018 issued by Notary Susi Aprilina, SH MKn. The Company started its commercial operations in 2018.

Selengkapnya di halaman RELF